ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
47 announcements with these filters
Vijaya Diagnostic Centre appointed Ms. Naga Vasudha Tadepalli as Company Secretary and Compliance Officer effective June 01, 2026. She brings sixteen years of legal and regulatory experience.
Vijaya Diagnostic Centre appointed Mr. Satyanaryana Murthy Chavali and Mr. Dipinder Singh Sekhon as Independent Directors. Their terms are five and two years, strengthening board governance.
Independent Directors Shekhar Prasad Singh and Satyanaryana Murthy Chavali ceased roles following tenure completion. Their departures were effective May 25, 2026, as per regulatory filings.
Vijaya Diagnostic reported a landmark FY26 with revenues crossing ₹800cr and Q4 revenue growth of 26.6%. The company is focusing on network expansion and high-end diagnostics like Genomics.
Vijaya Diagnostic Centre shareholders approved the appointment of two Independent Directors via postal ballot. The resolutions passed with requisite majority on May 09, 2026.
Vijaya Diagnostic Centre recommended a final dividend of ₹2 per equity share for FY26. The board will announce the record date and meeting schedule later.
Vijaya Diagnostic reported record FY26 revenue crossing ₹8,000 Mn with 41.4% EBITDA margins. Strategy focuses on deepening presence in South India and scaling West Bengal/Pune hubs.
Vijaya Diagnostic reported record Q4 FY26 revenue of ₹2,194 Mn (up 26.6% YoY) and FY26 revenue of ₹8,142 Mn, driven by pathology and radiology momentum.
Vijaya Diagnostic Centre reported FY26 revenue of ₹814.2 Crore, reflecting 19.5% YoY growth. The company achieved its highest-ever quarterly revenue, driven by strong pathology and radiology momentum.
Vijaya Diagnostic Centre approved FY26 financial results, recommended a ₹2 dividend, and announced a ₹4.20 Crore acquisition. Dr. D Nageshwar Reddy also retired as Independent Director.
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹219.4 Cr (+26.7% YoY) and net profit of ₹47.9 Cr (+37.2% YoY) for Q4 FY26.
Vijaya Diagnostic Centre reported FY26 standalone total income of ₹790.59 Crore. The board approved results and proposed a ₹2 per share dividend.
Vijaya Diagnostic Centre Limited has scheduled a Board Meeting for May 7, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 9, 2026.
Vijaya Diagnostic Centre Ltd has scheduled a Board meeting on May 07, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend. The trading window remains closed until May 09, 2026.
Vijaya Diagnostic Centre Limited has issued a postal ballot notice to seek shareholder approval for the appointment of Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola as Independent Directors. The voting period ends on May 9, 2026. This process ensures regulatory compliance and governance transparency for key leadership appointments.
Vijaya Diagnostic Centre Limited has issued a Postal Ballot Notice to seek member approval for appointing Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola as Independent Directors for five-year terms. Remote e-voting commences April 10, 2026, and ends May 09, 2026, with results announced by May 12, 2026.
Vijaya Diagnostic Centre Ltd reported net profit of ₹43.2 Cr (+22.4% YoY) for Q3 FY26.